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ABSTRACT 
 
 
Chemical Oxidation of Tryptic Digests to Improve  
 
Sequence Coverage in Peptide Mass Fingerprint  
 
Protein Identification.  (December 2003) 
 
Jessica Elaine Lucas, B.S., University of Texas at Dallas 
 
Chair of Advisory Committee:  Dr. David H. Russell 
 
 
 Peptide mass fingerprinting (PMF) of protein digests is a widely-accepted 
method for protein identification in MS-based proteomic studies.  Matrix-assisted laser 
desorption/ionization mass spectrometry (MALDI) is the technique of choice in PMF 
experiments.  The success of protein identification in a PMF experiment is directly 
related to the amount of amino acid sequence coverage.  In an effort to increase the 
amount of sequence information obtained in a MALDI PMF experiment, performic acid 
oxidation is performed on tryptic digests of known proteins.  Performic acid was chosen 
as the chemical oxidant due to the ease of use and to the selective oxidation of cysteine, 
methionine, and tryptophan residues.  In experiments performed in our laboratory, 
performic acid oxidation either increased or did not affect protein sequence coverage in 
PMF experiments when oxidized tryptic digests were analyzed by MALDI.  Negative 
mode MALDI data were acquired, as well as positive mode MALDI data, due to the 
enhanced ionization of cysteic acid-containing peptides in negative mode.  Furthermore, 
the confidence in a protein match is increased by observation of mass shifts indicative of 
cysteine, methionine, and/or tryptophan in oxidized peptide ion signals when comparing 
 iv
MALDI spectra prior to performic acid oxidation and after oxidation due to the low 
abundance of these residues in the majority of all known and hypothetical proteins.    
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CHAPTER I 
 
INTRODUCTION 
 
 
 Proteomics is the comprehensive study of the identity, function, and location of 
all proteins that comprise a unicellular or multicellular organism.1  Unlike genomics, 
where function is inferred through homology, proteomics directly studies the 
biochemical pathways necessary for life in order to determine biochemical details, such 
as:  protein localization within a cell or tissue, interactions of proteins with substrates or 
other proteins, and state-specific post-translational modifications.2  Identification of a 
protein or a mixture of proteins in a biological sample can be undertaken by several 
different analytical techniques (e.g., immunoassays, electrophoresis, mass spectrometry).  
Mass spectrometry (MS) provides the highest degree of selectivity, resolution, and 
sensitivity for the analysis of complex biological mixtures when compared with other 
standard methods.1,2  As such, MS has been applied to the analysis of a wide variety of 
proteins including lipoproteins3, glycoproteins4, and DNA-binding domains5.     
 Peptide mass fingerprinting (PMF) is the most common MS-based experiment 
for protein identification in current research.  PMF identification6-8 involves chemical or 
enzymatic digestion of a protein or protein mixture to yield peptides characteristic of a 
specific protein or proteins.  The resulting peptides are analyzed by MS as mass over 
charge (m/z), and the  peptide masses are then submitted to an online protein search 
engine, such as Mascot9, ProFound10,11, and MSFit12, for protein identification. 
This thesis follows the style and format of Analytical Chemistry. 
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These search engines “mine” annotated protein databases (e.g., Swiss-Prot13, NCBI14) 
that contain the amino acid sequences of known and hypothetical proteins from 
numerous organisms to match the peptide m/z data to theoretical digests.  Owing to the 
large amount of information contained in a protein database, additional experimental 
conditions can be specified to reduce the number of potential protein matches or “hits”.  
Search parameters that can be limited include:  specific organisms of sample origin, m/z 
error tolerance, post-translational or chemical modifications, and the proteolytic enzyme 
and/or chemical used in the digestion process.  Protein “scores” are included in search 
results to provide a measure of confidence for a possible protein match.  MOWSE, the 
scoring algorithm used in Mascot PMF searches, is based on the number of matching 
peptides per 10 kDa of a protein.7  The extent of percent sequence coverage, which is 
reported for all possible protein matches, adds to the confidence of a PMF identification 
in conjunction with the score.  In general, 15 to 30 percent sequence coverage has been 
determined to be the minimal amount necessary for a confident protein identification.8 
High confidence levels in PMF identification relate directly to the percent sequence 
coverage of a possible match. 
  The mass spectrometric technique of choice for PMF experiments is matrix-
assisted laser desorption/ionization (MALDI) mass spectrometry.  MALDI is less 
sensitive to impurities within a sample that can often interfere with analyte detection in 
other MS techniques15; therefore, MALDI requires less sample preparation and clean up 
making this technique generally more robust.   Ionization and desorption of analytes in 
MALDI requires the use of matrix, i.e., a molecule that absorbs at the wavelength of the 
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ionization laser (typically 337 nm produced by a N2 laser).  Theories pertaining to the 
mechanism of analyte protonation (or deprotonation for [M-H]-) have been proposed by 
several researchers.16  For example, excited-state proton transfer (ESPT) has been used 
to describe the ionization/desorption process.  That is, absorption of 337 nm radiation 
yields an electronically excited matrix molecule having a greater acidity which 
undergoes H+ transfer to an analyte.17  Matrix is typically in excess of 100 to 10,000 
fold. The matrices most commonly used are organic acids, such as α-cyano-4-
hydroxycinnamic acid (CHCA) and sinapinic acid (3,5-dimethoxy-4-hydroxycinnamic 
acid), which are dissolved in organic or aqueous solutions.   In a typical “dried droplet” 
MALDI sample spot, small aliquots of matrix solution and an aqueous sample are mixed 
in an Eppendorf tube by aspirating and expelling the mixture with a microliter pipet.  A 
microliter of the matrix-sample solution is deposited onto a MALDI sample plate and 
allowed to dry prior to analysis.   
 Proteolytic digestion by trypsin produces peptides with C-terminal lysine (K) or 
arginine (R).  A serum protein, for example, on average can generate ~ 1 tryptic peptide 
for every ~ 1500 Da, and tryptic peptides typically fall within a mass range of 500-4000 
Da.6,18-20  The molecular weight (MW) of a protein, in general, dictates the number of 
possible tryptic peptides observed (i.e, high MW proteins produce more tryptic 
peptides).  Although there are many peptides generated from digestion, some peptides 
that are deposited in a MALDI spot may not ionize and thus not detected.  There have 
been several reports that have attempted to identify the most important causal factors for 
these “analyte suppression effects.”  For example, hydrophobicity21, acid-base 
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character22 and sample morphology23 have all been identified as potential causal factors 
for peptide ion suppression.   In regards to acid-base character of an analyte in MALDI, 
an analyte with high basicity will, most often, be observed in a MALDI spectrum.22 
 Although an active area of research, analyte suppression is still a significant 
limitation to effective complex mixture analysis by mass spectrometry.  Suppression 
effects are most apparent in the highly complex mixtures commonly encountered in 
proteomics experiments, e.g., mixtures with greater than 10 protein components.  
Therefore, methods developed for complex peptide mixtures are optimized in terms of 
sensitivity/limit of detection to minimize the influence of ion suppression effects.   Thus, 
even though the minimal requirement for protein identification, as determined by Jensen 
and co-workers, is 15 to 30% coverage8, complex mixture analysis requires that the 
maximum number of peptides be detected.24 
 In an effort to enhance ionization of peptides in MALDI and thereby attain 
maximum percent coverage of a protein, covalent modifications of peptides and altering 
the solvent system of the matrix/sample solution have been studied by several 
researchers.  Arginine-terminated peptides ionize efficiently in MALDI and appear to 
suppress ionization of lysine-terminated peptides.21,25 Guanidation of lysine-terminated 
peptides, for example, was shown to increase the efficiency of ionization by increasing 
the basicity of lysine to be comparable to that of arginine-terminated peptides, thus 
allowing a higher probability of detection.26   In addition, since a lysine-terminated 
peptide is modified to cause a shift in mass, the presence of lysine in the peptide can be 
assumed and used in refinement of a protein database search.26  However, guanidation 
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experiments require sample preparation steps which degrade the throughput of the 
method and results in loss of peptide ion signal.  MALDI spectra have also been shown 
to be sensitive to the solvent and additives used in matrix/sample preparation.27,28  
Previous experiments performed in our laboratory indicate that MALDI ion signals are 
influenced by the polarity of the solvent system used in matrix/sample preparations in 
addition to what, if any, ion-pairing agent is added to the matrix/sample solution.28  
Thereby, the extent of interaction between matrix and analyte molecules is directly 
influenced by matrix/sample solvent composition.28 
 Selective oxidation of amino acids cysteine, methionine, and tryptophan has 
previously been utilized for protein denaturation and characterization.29-35  Cystine 
oxidation disrupts the disulfide bonds within a protein by cleaving the disulfide and 
results in two cysteic acid residues.  Free cysteine residues are oxidized as well.  The 
pKa of cysteic acid is 1.8936 versus that of cysteine, 8.3336; thereby dramatically altering 
the acidic character of the modified peptide.  Oxidation of methionine residues in 
peptides to methionine sulfoxide (addition of one oxygen) has been used by Gevaert, et 
al. to enhance the selectivity in RP-HPLC separations of protein digests, by increasing 
the hydrophilicity of the modified peptide.37  The complete oxidation of methionine 
results in methionine sulfone which further increases the hydrophilicity of the peptide.  
Products arising from hydrogen peroxide oxidation of free tryptophan amino acid and 
tryptophan-containing peptides have also been characterized in RP-HPLC separations.38  
The hydrophilicity of singly- and doubly-oxidized species is higher than that of native 
tryptophan.  Methionine, tryptophan, and cysteine oxidation have been applied recently 
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in biological mass spectrometry as well.32-35  Fast atom bombardment mass spectrometry 
(FAB MS) spectra of peptides containing methionine and tryptophan residues before and 
after chemical oxidation were compared by Wagner and Fraser (1987).33  Methionine 
and tryptophan both incorporated one oxygen atom to cause a shift in m/z; therefore, a 
16 Da mass shift indicates the presence of either methionine or tryptophan after 
oxidation.   
 Amino acid residues can be oxidized by a variety of chemical reagents.  DMSO 
(Dimethylsulfoxide)/HCl/acetic acid33,35,38, Fe(III)/ascorbic acid/O238, hydrogen 
peroxide37,38 and peracids29-32,38 are a few reagents commonly used for oxidation.  
Unfortunately, performing oxidations with DMSO, for example, only leads to partial 
oxidation of methionine and/or tryptophan33 and DMSO has been shown to degrade 
MALDI spectral quality.15   During performic acid oxidation29-32, cysteine (or cystine) 
incorporates three (or six) atoms of oxygen (Figure 1A), methionine acquires two atoms 
of oxygen to become methionine sulfone (Figure 1B), and tryptophan, shown in Figure 
2, oxidizes by incorporation of one, two, or three atoms of oxygen, β-(3-
oxyindolyl)alanine, N-formylkynurenine, and hydroxy-N-formylkynurenine, 
respectively.  In addition, cysteine, methionine, and tryptophan have a low frequency of 
occurrence in proteins:  cysteine abundance ~ 1.75%; methionine abundance ~ 2.25%; 
tryptophan abundance ~ 1.25%.39  Thus, the selectivity of performic acid oxidation can 
be used to refine PMF identifications, particularly in instances where a PMF query 
returns several possible protein matches.   To verify the sites of oxidation accessible to 
performic acid oxidation, a set of preliminary studies were performed in our laboratory.  
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Figure 1.   Effect of performic acid on cysteine and methionine.  A) Oxidation of cysteine to 
cysteic acid using performic acid.  B) Oxidation of methionine to methionine sulfone using 
performic acid.  
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Three peptides, KPVTDAENCHLAR, AMTNLR, and TSDANINWNNLK, were 
isolated using tandem mass spectrometry from a MALDI tryptic digest sample of 
transferrin.  TOF-TOF data for three peaks corresponding to oxidized peptides from an 
oxidized transferrin tryptic digest are shown in Figures 3-5.  Figure 3 shows the 
fragmentation of  KPVTDAENC(O3)HLAR; Figure 4 shows AM(O2)TNLR; Figure 5 
shows TSDANINW(O)NNLK.  In Figure 3, the mass difference between y5 
([C(O3)HLAR+H]+) and y4 ([HLAR+H]+) corresponds to the mass of a cysteic acid 
residue (151 Da).  The fragment ions corresponding to the loss of methionine sulfone are 
not observed in Figure 4, although with the partial sequence information generated from 
y-ion and b-ion series, the site of oxidation can be limited to methionine or alanine.  
Under performic acid oxidation, alanine is not oxidized; this is illustrated by Figure 3 
where the mass difference between y8 ([AENC(O3)HLAR+H]+)  and y7 
([ENC(O3)HLAR+H]+) corresponds to the residual mass of alanine (71 Da).  Therefore, 
methionine is the only amino acid residue oxidized by performic acid oxidation in 
AMTNLR.  In Figure 5, the mass difference between y5 ([W(O)NNLK+H]+) and y4  
([NNLK+H]+) equals the mass of a β-(3-oxyindolyl)alanine residue.  MS/MS data 
indicates that the specific sites of oxidation is cysteine, methionine, and tryptophan; 
hence, changes in mass of a peptide containing one or more of an oxidized residue can 
provide amino acid composition information for a tryptic peptide.   That is, the 
additional knowledge of the presence of cysteine, methionine, and/or tryptophan, each of 
which have a low frequency of occurrence in known and hypothetical proteins, greatly 
enhances the confidence of proteins identified by PMF experiments.  
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Figure 2.  Oxidation of tryptophan with performic acid.  A) Tryptophan residue in 
unoxidized state; B) Singly-oxidized tryptophan, β-(3-oxyindolyl)alanine; C) Double-
oxidized tryptophan, N-formylkynurenine; D) Triply-oxidized tryptophan, hydroxy-N-
formylkynurenine.  *Position of phenyl hydroxyl group variable. 
* 
 10
80 220 360 500 640 780
Mass (m/z)
0
100
%
 In
te
ns
ity
b4
a5
b5
y1
b3
b2
TN
y2-NH3
y2 y3-NH3
y4-NH3
R [M+H]
+
y1-NH3
%
 In
te
ns
ity
80 380 680 980 1280 1580
Mass (m/z)
0
100
%
 In
te
ns
ity
y1
y2
y3
y4
y5 y6
y7 y8 y9 y10 b12b11
b10 [M+H]+
%
 In
te
ns
ity
Figure 3.  TOF-TOF spectrum of the peptide sequence KPVTDAENC(O3)HLAR. 
 
Figure 4.  TOF-TOF spectrum of the peptide sequence AM(O2)TNLR.  
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 Here, oxidation, using performic acid, is assessed to determine if percent 
coverage in PMF identification yields a higher confidence level.  Performic acid was 
chosen as the oxidant due to its high vapor pressure, ease of use, lack of additional 
sample preparation prior to MALDI analysis to remove any contaminants, and the 
relative amino acid specificity when compared with other methods of chemical 
oxidation.  Although data obtained in negative mode MALDI are typically not used in 
PMF identification, negative ions are included in the PMF identification experiments to 
determine the effect of oxidation on peptide ions observed in negative mode MALDI.  
With the ability to observe peptides before and after oxidation, additional information 
about the primary structure of a peptide is inferred, thus adding to the confidence level 
of protein identification and the ability to refine PMF protein identifications.  Further 
development of a high-throughput approach using “on-target” oxidation32 allows 
MALDI analysis of the same dried-droplet sample spot with similar results obtained 
using the “in-solution” oxidation.  
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CHAPTER II 
 
EXPERIMENTAL 
 
 
SAMPLE PREPARATION 
 
Protein Denaturation and Tryptic Digestion 
 Commercially available proteins (Table 1) were obtained from Sigma-Aldrich 
and stock solutions were made for each with concentrations varying from 1 to 6 mg/mL 
distilled and deionized (ddI) H2O (Millipore, in-house).  Beta casein utilized in these 
studies contains phosphorylated sites; alpha casein was purchased in the  
dephosphorylated form, and all other proteins are assumed to contain no post-
translational modifications.  Molarity of protein stock solutions was calculated, and the 
volume corresponding to 200 pmol of each bulk protein was transferred to 500 mL 
Eppendorf vials.  50 mM NH4HCO3 was added to each 200 pmol protein solution to 
reach a 50 µL total volume.  For thermal denaturation according to Park et al, protein 
vials were heated in a 90°C water bath for 20 minutes and then quickly transferred to the 
freezer for 5 minutes.40   
 Sequencing-grade trypsin (Promega) was diluted in 50 mM acetic acid to a 
concentration of 0.05 µg/mL.  The optimal amount of trypsin for digestion of each 
protein was calculated based on the 1:50 (g trypsin: g protein) ratio.  The respective 
amount of trypsin was added to each protein solution, and the vials were placed in a 
37°C water bath and allowed to digest overnight (~14 h).  Trypsin activity was quenched 
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by placing the protein vial in the freezer for 20 minutes.  2 µL of each sample was used 
for MALDI MS analysis.   
Oxidation 
 Performic acid was prepared based on the method described by Hirs.31  Formic 
acid (88%, EM Science) and hydrogen peroxide (30%, EM Science) were mixed 32:1 
(v/v) in a 1.5 mL Eppendorf tube and allowed to “age” for 120 minutes at room 
temperature.  Half of the digested protein samples  (25 µL) were evaporated in a speed-
vac to dryness, then reconstituted with 50 µL 88% formic acid and 10 µL methanol (EM 
Science, HPLC grade).  All samples were then placed in a freezer at -8°C for 30 minutes.  
40 µL of performic acid, in excess, was added to each sample and then returned to -8°C 
for 180 minutes to oxidize.  Immediately after the incubation period, ~ 0.5 mL of cold 
ddI water was added to each sample, and all samples were evaporated to dryness in a 
speed-vac to halt oxidation.  Protein samples were then reconstituted with 25 µL of ddI 
water for MALDI analysis. 
 For “on-target” oxidation, performic acid was made in a 1:9 (v/v) of 30% 
hydrogen peroxide and 88% formic acid respectively.  This ratio was chosen for “on-
target” oxidation due to the higher concentration of performic acid formed (~1 µmol/µL) 
and the length of the incubation period (~10 min) stemming from evaporation of the 
oxidizing solution.  “Aged” performic acid was mixed in methanol (EM Science, HPLC 
grade) at ratios of 1:1, 2:1, 3:1 (v/v) respectively and deposited on a dried-droplet tryptic 
digest of thermally-denatured BSA or transferrin.  Other ratios were made of performic 
acid, acetonitrile (EM Science, HPLC grade), and methanol at 1:1:1, 2:2:3, 1:2:1, 1:2:2 
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(v/v/v) respectively prior to deposition onto a dried-droplet tryptic digest MALDI 
sample.  Another procedure of first applying 1:1 (v/v) methanol and acetonitrile to the 
dried-droplet sample and then adding 1 µL of performic acid to the droplet was also 
utilized for the studies reported in Chapter VI. 
Protein Digest Mixtures 
 Protein digest mixtures were made with five, ten, and fifteen protein components.  
Unused portions of thermally denatured protein digest samples used in Chapter IV were 
used to make multiple-component protein digest mixtures. Unoxidized and oxidized 
protein digests were added at 40 pmol protein content (exceptions being the subunits of 
alpha casein at 20 pmol) to have a total protein content of 200, 400, and 600 pmol for the 
5, 10 and 15 component digest mixtures, respectively.  The total protein molarity of 4 
µM was kept constant for each mixture.   One unoxidized and oxidized mixture was 
made for each of the five, ten, and fifteen protein digest mixtures.  
MALDI Sample Preparation 
 For MALDI analysis of the samples, 2 µL of each tryptic digest was mixed in 
separate vials with 2 µL of ddI water and 4 µL of matrix solution (10-25 mg α-cyano-4-
hydroxycinnamic acid (Sigma-Aldrich, recrystallized) in 1 mL methanol (EM Science, 
HPLC grade)).   1 µL, equivalent to 1 pmol of digested protein, of each sample was then 
deposited on a stainless-steel MALDI sample stage (Applied Biosystems) and allowed to 
crystallize at room temperature.  All samples were analyzed in both positive and 
negative modes ( i.e., both positive and negative ions produced by the MALDI event 
were detected in separate experiments). 
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INSTRUMENTATION 
MALDI  Mass Spectrometry 
 A commercially available matrix-assisted laser desorption/ionization (MALDI) 
delayed-extraction reflected time-of-flight (DE-RTOF) mass spectrometer, Voyager 
STR (Applied Biosystems), was used for PMF experiments in positive and negative ion 
modes.  Extraction delay time was kept in the range of 150-165 ns for optimum 
resolution and sensitivity.  Grid voltage was set at 68% of the accelerating voltage (± 20 
kV).  Laser power was adjusted within the range of 2100-2400 arbitrary units (a.u.) for 
positive mode and 2200-2500 (a.u.) for negative mode.  Mass range was 500-5000 m/z 
for peptide detection.   The matrix used was α-cyano-4-hydroxycinnamic acid (CHCA) 
in concentrations of 10-20 mg/mL methanol (HPLC grade).   
 All spectra were averages of 1000 to 1500 laser shots at a frequency of 20 Hz. 
Instrument calibration was performed externally in both polarities using the 
monoisotopic masses of des-Arg1-bradykinin ([M+H]+ = 904.4681; [M-H]- = 902.4525), 
angiotensin I ([M+H]+ = 1296.6853; [M-H]- = 1294.6697 m/z), glu1-fibrinopeptide B 
([M+H]+ = 1570.6774; [M-H]- = 1568.6618), adrenocorticotropin hormone 1-17 
([M+H]+ = 2093.0867; [M-H]- =  2091.0711), and adrenocorticotropin hormone 18-39 
([M+H]+ = 2465.1989; [M-H]- =  2463.1833).   
 In Chapter V, internal calibration was performed using femtomolar amounts of 
des-Arg1-bradykinin, angiotensin I, glu1-fibrinopeptide B, and adrenocorticotropin 1-17.  
In MALDI spectra where the internal calibrants were not observed, positive mode was 
calibrated with one low m/z monoisotopic peak:  protonated CHCA matrix (trimer) 
 18
([M+H]+ = 568.1356), sodiated and hydrated CHCA matrix (tetramer) with 3 Na and 
H2O ([M+H]+ = 841.1347), or trypsin auto-cleavage peptide (100-107) VATVSLPR 
([M+H]+ = 842.5100), and one high m/z monoisotopic peak:  α-hemoglobin chain tryptic 
peptide (17-31) VGGHAAEYGAEALER ([M+H]+ = 1529.7342), phosphorylase tryptic 
peptide (256-269) DFNVGGYIQAVLDR ([M+H]+ = 1566.7910), or phosphorylase 
tryptic peptide (507-519) IGEEYISDLDQLR ([M+H]+ = 1550.7696).  Negative mode 
was calibrated with CHCA matrix (trimer) with K ([M-H]- = 604.0759) and transferrin 
tryptic oxidized peptide (595-607) KPVTDAENC(O3)HLAR ([M-H]- = 1499.6907) or 
α-hemoglobin tryptic peptide (17-31) VGGHAAEYGAEALER ([M-H]- = 1527.7186).  
MALDI data was manipulated with Data Explorer software (Applied Biosystems). 
 Tandem MS data was generated with an Applied Biosystems 4700 Proteomics 
Analyzer (TOF-TOF).  Positive mode data was acquired with a 200 Hz Nd-YAG laser at 
355 nm; 500 laser pulses were averaged for each spectrum.  CHCA at 10 mg/mL 
methanol (EM Science, HPLC grade) was mixed 1:1 with the sample and deposited onto 
a stainless-steel MALDI sample plate in dried-droplet fashion.  Collision-induced 
dissociation (CID) was done using air as the collision gas.   
PROTEIN DATABASE SEARCHING 
 MALDI data was submitted to Mascot and/or ProFound protein database search 
engines.  ProFound was utilized primarily for oxidized samples due to the option 
available for user-defined chemical modifications.  Monoisotopic masses of all data 
were queried with a mass error of ± 150 ppm and allowed up to one tryptic missed 
cleavage.  Taxonomic categories specified in the PMF queries were either “Other 
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mammalia” or “Other chordata” depending on the origin of the protein digest data.  
Negative ion data were first converted to [M] in Excel by addition of 1.0078 Da for 
hydrogen prior to submission due to the absence of an [M-H]- option for queried data.  
Percent coverage is automatically calculated by the search engine, although percent 
coverage was “corrected” for instances where the amino acid sequence encoded for the 
“pro-protein” indicating the signal peptide was incorporated into the overall percent 
coverage by the search engine.  Percent coverage was also corrected for proteins whose 
tryptic peptides, with zero missed cleavages, fell out of the m/z 500-5000 data range.  
The total correction factor for each protein is listed in Table 1.  For example, beta casein 
(BC in Table 1) has a total correction factor of +54% due to tryptic peptides that fall out 
of the mass range (m/z 500-5000) and due to a signal peptide.  Two tryptic peptides of 
BC have a mass above 5000 Da that together contain a total of 105 amino acids out of 
the entire sequence of 224 amino acids in BC which is calculated as 47%.  In addition, 
BC contains a signal sequence of 15 amino acids that is cleaved off in expressed protein; 
therefore, the total correction factor of BC is 47% + 7% = 54%. 
 All tabulated data shown is calculated from the three trials (N =3) performed for 
each experimental sample set.  The standard deviation from the calculated average of 
each sample set shows the variation in the three experimental trials.  Due to the small 
number of trials performed (N = 3), the sample average and deviation may not be the 
optimal estimators of the true percent coverage for each protein sample.  
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CHAPTER III 
 
PERCENT SEQUENCE COVERAGE WITHOUT THERMAL 
 
DENATURATION OF PROTEINS AND IN-SOLUTION OXIDATION 
 
 
BACKGROUND 
    
 Oxidation has been utilized as a method of protein denaturation, primarily with 
respect to disulfide bond cleavage29,31, although methionine oxidation also alters 
hydrophobicity.37  Previous studies have utilized oxidation in fast-atom bombardment 
mass spectrometry (FAB-MS) to identify sites of disulfide bonds (or cystines) in 
proteins.  Van de Weert, et al., observed oxidized tryptophan-containing peptides in a 
MALDI experiment and noted the increased signal intensity of the peptide after the 
tryptophan oxidation.35  Extensive oxidation, performed by Sharp, et al., utilizes 
chemically-generated hydroxyl radicals for aggressive and non-specific oxidation of 
proteins expressed on the surface of a cell.41  Specific amino acid residues become 
oxidized under performic acid oxidation; tryptophan, methionine, and cysteine residues 
become oxidized.   
 Performic acid oxidation of tryptic peptides may increase overall sequence 
coverage by altering the ionization efficiency of the oxidized peptide.  Although thermal 
denaturation of proteins prior to digestion greatly facilitates trypsin activity,  performic 
acid oxidation of a tryptic protein digest, alone, is considered in this study of PMF 
protein identification utility.  
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RESULTS AND DISCUSSION 
 In general, the positive ion MALDI spectra for both oxidized and un-oxidized 
tryptic protein digests have a similar appearance (Figure 6).  The peptide ion with the 
highest intensity signal remains the same in positive ion mass spectra before and after 
performic acid treatment. The relative peptide ion signal abundance of other peptides 
also approximately remain unchanged before and after performic acid oxidation.  The 
effect of oxidation on tryptophan-containing peptides is illustrated by data shown in 
Figure 7.  Simply by visual inspection of an oxidized tryptic digest MALDI spectrum, 
peaks corresponding to peptides with tryptophan can be identified.  The first peak in the 
triplet of peaks observed from oxidization of  tryptophan corresponds to the singly-
oxidized species (∆ m/z = +15.99); the second peak is doubly-oxidized tryptophan (∆ 
m/z = +31.99); the third is the triply-oxidized species (∆ m/z = +47.99).  In every 
oxidized tryptic digest in this study, the singly-oxidized tryptophan peptide peak is the 
most dominant of the three oxidized tryptophan peaks.  The ion signal intensity 
corresponding to the doubly-oxidized species ranges from 20 to 85% of the singly-
oxidized species; the third, triply-oxidized tryptophan peak can be completely absent in 
the spectrum or comprise up to 70% intensity relative to the singly-oxidized peak.  In the 
study reported by Van der Waart et al., the ion signal intensities of peptides with 
oxidized tryptophan were greater versus the ion signal intensities of the unoxidized 
tryptophan-containing peptides.35  From observations reported in this laboratory, 
peptides containing unoxidized tryptophan typically had higher relative signal intensity  
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Figure 6.  Positive mode MALDI spectra of Phos before (A) and after (B) in-solution 
performic acid oxidation. 
Figure 7.  Positive mode MALDI spectra of Lys tryptic peptide GTDVQAWIR after in-
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than when oxidized.  Although MALDI ion signal cannot be considered a quantitative 
measure of the peptides deposited on the sample plate42, the probable reason for the 
decline in signal intensity is due to one peptide species being altered into three oxidized 
forms with separate ion signals, similar to the decrease in ESI signal observed due to 
multiple charge states.   For the majority of protein digests studied here, more 
tryptophan-containing peptides were observed in unoxidized positive mode MALDI 
data. 
 The effect of performic acid oxidation of methionine residues in peptides appears 
to enhance the number of methionine sulfone-containing peptides detected in positive 
mode MALDI data.  When comparing relative signal intensity of peaks corresponding to 
peptides with methionine residues, the respective oxidized species ion signal was similar 
before and after oxidation in both polarities.  Adjacent peaks corresponding to 
unoxidizable peptides were used to gauge any change in relative signal intensity of the 
methionine-containing peptides.  Despite no relative change in ion signal, more peptides 
containing methionine are observed in positive mode MALDI data after oxidation.  An 
explanation for the observance of more methionine-containing peptides after oxidation 
could be due to the change in chemical properties of the sample mixture.  The more 
dominant ion signal, in general, corresponded to peptides with no oxidizable residues 
before and after oxidation in positive mode MALDI data, although after oxidation, there 
was a slight decrease in signal intensity.   Peptide-peptide suppression effects22 that are 
caused by the peptides with high ion signal intensity (i.e., peptides having high basicity) 
may have lessened after oxidation. 
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 Cysteic acid-containing peptides, as well as cysteine-containing peptides, can be 
observed in positive ion MALDI spectra although not as often when compared to 
methionine sulfone-containing peptides.  When PMF analysis was performed on 
unoxidized samples, a few small peptides (m/z 600-1000) contained cysteine.  Very 
rarely was a larger peptide (m/z 1500-3500) with a cysteine residue detected.  The lack 
of detection of peptides with cysteine residues could stem from the low efficiency of 
tryptic digestion due to non-denatured proteins.  After oxidation, cysteic acid-peptides 
were observed in positive mode although some ions were sodiated and would not be 
identified in PMF identification unless the [M+Na]+ ion was specified in the protein 
search parameters.  Overall, the maximum detection of cysteic acid-containing peptide 
ions occurred when data acquisition was performed in negative mode MALDI.   
 PMF experiments for the majority of the proteins used yielded a percent 
coverage greater than 30% in unoxidized, positive mode as represented in Table 2.  
Ovalbumin, ribonuclease A, and carbonic anhydrase tryptic digests analyzed by MALDI 
had low percent coverage due to the need to denature the protein prior to digestion.  Park 
et al. clearly observed this trend in prior experiments.43  After undergoing performic acid 
oxidation, percent coverage in positive mode MALDI for each protein was within to 
slightly lower of the unoxidized percent coverage range with carbonic anhydrase being 
the exception.      
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55 ± 597 ± 293 ± 495 ± 6Hemo-α
55 ± 1254 ± 1362 ± 659 ± 4AC-S1
51 ± 556 ± 928 ± 1447 ± 11TF
63 ± 4N/AN/A9 ± 5Ribo
59 ± 257 ± 854 ± 463 ± 2Phos
N/AN/AN/AN/AOva
62 ± 1386 ± 370 ± 789 ± 2Myo
40 ± 343 ± 237 ± 549 ± 6Lys
81 ± 1096 ± 283 ± 284 ± 1Hemo-β
54 ± 571 ± 552 ± 375 ± 2CytC
26 ± 244 ± 910 ± 420 ± 7CA
55 ± 743 ± 224 ± 338 ± 2BSA
74 ± 381 ± 473 ± 386 ± 2BC
36 ± 1134 ± 1127 ± 244 ± 2Ald
50 ± 046 ± 648 ± 150 ± 1ADH
19 ± 937 ± 1330 ± 961 ± 6AC-S2
Oxidized 
Negative
Oxidized 
PositiveNegativePositive
Percent Sequence Coverage*,♣
Protein
* Standard Deviation figured for N=3; ±1σ.
♣ Corrected percent coverage using Correction factors listed in 
Table 1.
Table 2.  Average percent coverage and standard deviation for non-denatured 
protein samples digested with trypsin. 
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Figure 8.  Negative mode MALDI spectra of Phos before (A) and after (B) in-solution 
performic acid oxidation.  *Peaks corresponding to cysteine-containing peptides.  No 
cysteine-containing peptides were identified in spectrum A. 
* 
* * * * 
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 Negative ion spectra for unoxidized samples differed significantly from oxidized 
samples.  After PMF identification, more sequence information was typically obtained 
from negative mode MALDI of oxidized tryptic digests due to detection of peptides with 
cysteic acid.   Cysteic acid-containing peptides dominate the negative ion spectra due to 
the high acidic character of the oxidized residue.  Representative negative ion spectra of  
before and after oxidation are shown in Figure 8. Unoxidized, negative ion MALDI data 
for each protein queried in Mascot had a percent coverage similar to or significantly less 
than positive ion data.  A possible explanation for this observation may be due to the 
basic C-terminal side-chain of the peptides as the primary charge carrier.44   Typically, 
the peptides observed in negative mode are also present in positive mode of unoxidized 
digests; thus making data acquisition in positive mode MALDI more practical in 
detection of peptide ions for PMF identification.   As indicated in Table 3, combining the 
data of positive and negative mode MALDI does not increase overall sequence coverage.   
Combined positive and negative data for oxidized digests were similar for:  AC-S1, 
ADH, BC, CytC, Hemo-α, Myo, and TF, or higher for:  Ald, BSA, CA, Hemo-β, Lys, 
Phos, and Ribo, than unoxidized data combined with the exception of AC-S2 where 
unoxidized data was slightly higher.  For the higher percent coverage gained from 
oxidized digest data, the higher possible number of cysteine-containing tryptic peptides 
follow except TF.  In cases where percent coverage is similar, the number of possible 
cysteine-containing peptides is low, with the exception of TF.  The total-combined 
percent coverage (Table 3) indicates that when unoxidized and oxidized data are  
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78 ± 269 ± 452 ± 13TF
63 ± 463 ± 4N/ARibo
76 ± 273 ± 265 ± 2Phos
N/AN/AN/AOva
99 ± 286 ± 389 ± 2Myo
71 ± 660 ± 149 ± 6Lys
94 ± 594 ± 585 ± 2Hemo-β
99 ± 097 ± 298 ± 2Hemo-α
76 ± 575 ± 569 ± 2CytC
46 ± 1344 ± 922 ± 8CA
73 ± 962 ± 638 ± 1BSA
87 ± 084 ± 186 ± 2BC
62 ± 659 ± 443 ± 1Ald
75 ± 173 ± 171 ± 1ADH
65 ± 650 ± 261 ± 3AC-S2
73 ± 160 ± 970 ± 5AC-S1
Total-
Combined
Oxidized   
+/-
Unoxidized 
+/-
Combined Percent Coverage*,♣
Protein
* Standard Deviation figured for N=3; ±1σ.
♣Corrected percent coverage using Correction factors listed in 
Table 1.
Table 3.  Combined percent coverage of non-denatured protein digests.  
Positive and negative MALDI data are combined for unoxidized, 
oxidized separately, and all data is combined to give a total-combined 
coverage. 
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combined both contribute somewhat complimentary sequence information to the 
sequence coverage of the protein.                                        
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     CHAPTER IV 
PERCENT SEQUENCE COVERAGE WITH THERMAL 
 
DENATURATION AND IN-SOLUTION OXIDATION 
 
 
BACKGROUND 
 
 Protein denaturation by chemical or extrinsic means has proved to be helpful in 
enhancing proteolytic digestion.45  Inter- and/or intramolecular interactions are disrupted 
allowing proteases access to internal cleavage sites usually buried within the tertiary or 
quaternary structure of a native protein.  The primary step in increasing overall sequence 
coverage is to start at the enzymatic digest process.  Chemical denaturants (e.g., urea, 
sodium dodecylsulfate, guanidine HCl) effectively denature proteins in solution although 
use of these additives can cause problems in down-stream analysis.  MALDI has been 
shown to be tolerable of some chemical additives, yet relatively low concentrations of 
specific additives (e.g., ionic detergents) can degrade spectral quality.15  Thermal protein 
denaturation was proposed as a “mass spectrometry-friendly” approach to protein 
denaturation as no additives are required.40,43  Comparing thermally-denatured protein 
digests to non-denatured digests, the overall percent coverage of a protein increases 
when thermal denaturation is performed prior to proteolytic digestion, although percent 
coverage of some proteins decline after thermal denaturation.43   
 Thermal denaturation has been shown to enhance the efficiency of protein 
enzymatic digestion relative to no increased temperature pretreatment.  Performic acid 
oxidation of non-denatured protein digests has also shown utility in obtaining higher 
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sequence coverage by altering the chemical nature of the peptides.  To compare both 
methods, tryptic digestion of thermally-denatured proteins before and after oxidation are 
compared to the results of Chapter III.  The combination of thermal denaturation and 
performic acid oxidation further enhances overall sequence coverage and ultimately 
leads to higher confidence level protein identifications in PMF experiments. 
RESULTS AND DISCUSSION 
 Thermal denaturation prior to digestion by trypsin aided in increasing the percent 
sequence coverage (Table 4) of aldolase, carbonic anhydrase, albumin, and myoglobin, 
and allowed detection of ovalbumin and ribonuclease that were, for the most part, absent 
in the study done in Chapter III.   The secondary/tertiary structure of the aforementioned 
proteins are compact and highly resistant to tryptic digestion.45  The remainder of the 
proteins (AC-S1, AC-S2, ADH, BC, CytC, Hemo-α, Hemo-β, Lys, Phos, TF) yielded 
similar to lower average percent coverage.   There are several potential explanations for 
the loss of percent coverage for some thermally-denatured proteins.  The generation of 
more tryptic peptides may have elicited peptide-peptide suppression, where a peptide of 
higher ionization efficiency, not present in the non-denatured sample, causes the 
suppression of a previously detected peptide that has a lower ionization efficiency.   
 Combined sequence coverage of positive and negative ion MALDI data, 
unoxidized, oxidized, and both unoxidized/oxidized together (total-combined), was 
determined by PMF identification (Table 5).  As stated in Chapter III, MALDI data 
acquired in negative mode contributed little to no additional peptide information to the 
combined percent sequence coverage when the tryptic digest is not oxidized.  Thus, only  
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62 ± 1480 ± 1350 ± 1582 ± 14Hemo-α
63 ± 862 ± 1266 ± 268 ± 5AC-S1
64 ± 850 ± 141 ± 366 ± 6TF
77 ± 276 ± 439 ± 150 ± 4Ribo
59 ± 459 ± 549 ± 459 ± 6Phos
44 ± 747 ± 422 ± 949 ± 7Ova
73 ± 685 ± 678 ± 596 ± 5Myo
58 ± 555 ± 145 ± 957 ± 7Lys
60 ± 1286 ± 859 ± 469 ± 2Hemo-β
55 ± 662 ± 125 ± 1179 ± 12CytC
42 ± 267 ± 449 ± 1871 ± 5CA
68 ± 1048 ± 938 ± 448 ± 8BSA
73 ± 384 ± 272 ± 287 ± 0BC
76 ± 858 ± 1148 ± 851 ± 6Ald
55 ± 548 ± 357 ± 154 ± 6ADH
22 ± 745 ± 1029 ± 1154 ± 13AC-S2
Oxidized 
Negative
Oxidized 
PositiveNegativePositive
Percent Sequence Coverage*,♣
Protein
* Standard Deviation figured for N=3; ±1σ.
♣ Corrected percent coverage using Correction factors listed in 
Table 1.
Table 4.  Average percent coverage and standard deviation for thermally-
denatured protein samples digested with trypsin. 
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74 ± 357 ± 464 ± 2TF
84 ± 481 ± 261 ± 13Ribo
73 ± 170 ± 163 ± 4Phos
69 ± 657 ± 644 ± 6Ova
99 ± 186 ± 399 ± 1Myo
68 ± 667 ± 763 ± 4Lys
86 ± 586 ± 569 ± 2Hemo-β
99 ± 083 ± 1199 ± 0Hemo-α
82 ± 670 ± 279 ± 12CytC
75 ± 069 ± 573 ± 2CA
78 ± 272 ± 350 ± 9BSA
87 ± 083 ± 187 ± 0BC
90 ± 290 ± 264 ± 3Ald
77 ± 271 ± 575 ± 3ADH
66 ± 447 ± 1363 ± 6AC-S2
74 ± 173 ± 373 ± 0AC-S1
Total-
Combined
Oxidized   
+/-
Unoxidized 
+/-
Combined Percent Coverage*,♣
Protein
* Standard Deviation figured for N=3; ±1σ.
♣Corrected percent coverage using Correction factors listed in 
Table 1.
Table 5.  Combined percent coverage of thermally-denatured protein 
digests.  Positive and negative MALDI data are combined for unoxidized, 
oxidized separately, and all data is combined to give a total-combined 
coverage. 
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positive mode MALDI spectra need be acquired when a tryptic digest is unoxidized.  On 
the other hand, the protein information retrieved when combining positive and negative 
ion data of an oxidized protein tryptic digest increased the overall percent sequence 
coverage relative to only positive ion data of oxidized samples.  In an extreme case, that 
of transferrin, 80% of the peaks observed from negative mode MALDI of the oxidized 
digest corresponded to cysteic acid-containing peptides that were not observed in 
positive mode.  Here, oxidized negative mode contributed more peptide information than 
oxidized positive mode data.  The total-combined percent coverage of each protein when 
compared to that of Chapter III was within the average range for the majority of 
samples.  Ald, CA, Ova, and Ribo, on the other hand, obtained a higher grand percent 
coverage due to thermal denaturation.   
 One reason for the enhanced percent coverage observed for oxidized relative to 
non-oxidized protein digest samples is related to the ability of chemical oxidation to 
reduce spectral overlap in the case of some isomass tryptic peptides.  Figure 9 highlights 
the case of two near-isomass peptides from ovalbumin.  Prior to chemical oxidation, the 
two sequences of DILNQITKPNDVYSFSLASR ([M+H]+ = 2281.18) and 
VTEQESKPVQMMYQIGLFR ([M+H]+ = 2284.15) exhibit a high degree of spectral 
overlap, however, upon performic acid oxidation the two signals are easily 
distinguishable as VTEQESKPVQMMYQIGLFR contains two methionine residues.  
 The high standard deviation between similar trials, in both Chapter III and IV, 
can be attributed to the “spot-to-spot” reproducibility46 in MALDI spectra.  Data 
generated for each sample in a trial was performed on different days, while instrumental  
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Figure 9.   Ova tryptic peptides DILNQITKPNDVYSFSLASR (1) and 
VTEQESKPVQMMYQIGLFR (2) prior to performic acid oxidation (A) and after 
performic oxidation (B) in positive mode MALDI spectra. 
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parameters and sample preparation was kept constant in each sample.  Variations in the 
surface of a MALDI sample plate can influence the uniformity of matrix/sample 
crystallization which, in turn, can influence the abundance/location of “sweet spots”.  
Sweet spots are regions within a MALDI sample spot that yield spectra with high signal-
to-noise of the analyte(s).46  
 Generally, chemical oxidation with performic acid increases the percent coverage 
for single component protein samples through decreased peptide ionization suppression 
effects and decreased spectral overlap.  As previously noted by Park, et al., thermal 
denaturation generally increases the number of peptides observed by mass spectrometry, 
although it is apparently not optimal for all proteins.43 
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CHAPTER V 
PERCENT SEQUENCE COVERAGE IN THERMALLY-DENATURED 
 
AND IN-SOLUTION OXIDIZED PROTEIN DIGEST MIXTURES 
 
 
BACKGROUND 
 
 Complex biological matrices often contain large amounts (1 µg/mL to 50 
mg/mL) of protein.47  Blood, saliva, urine, etc. are all comprised of many proteins, along 
with lipids, salts, etc., at different concentrations.  This analogy can be extended to a 
microscopic level with cells and the organelles within the cells.  MS-based proteomics is 
continuously evolving to detect to identity and expression level of proteins in any given 
biological sample.  The scope of proteomics extends further to determine protein-
substrate (e.g., protein-protein, protein-DNA, protein-lipid, etc.) interactions, protein 
post-translational modifications, and phenotype-dependant expression levels. 
 Previous research by Park et al.,43 showed that a separation step prior to 
enzymatic digestion and MALDI analysis is not necessary in some circumstances of 
protein mixtures.  Model protein mixtures made up of nine commercially-available 
proteins were thermally denatured and then digested with trypsin.  MALDI data was 
then queried in a protein database search engine to identify the protein mixture 
components by PMF.  All nine proteins were identified by PMF with sequence coverage 
varying from 14 to 48%.  The time and data storage space needed to accurately identify 
each protein component are less than that required for a two-dimensional liquid 
chromatography-mass spectrometry experiment.  Thus, thermally-denatured, 
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enzymatically-digested protein mixtures followed by MALDI analysis is more 
amendable for high-throughput analysis and minimal sample volume. 
 Confidence levels in a PMF experiment can be increased by several parameters.  
Obtaining high mass accuracy with internal calibrants aids in reducing the number of 
false positives retrieved from a PMF query.48  Also, knowledge of the origin of the 
sample limits protein homologues or related protein-families from other species in being 
falsely identified.  Short of MS-MS analysis for primary structure information, any 
knowledge of possible residues within a peptide greatly enhances the confidence level of 
proteins identified by PMF experiments.  Performic acid oxidation, specifically, causes 
mass shifts in peptide ion peaks containing cysteine, methionine, and/or tryptophan.  
Moreover, the extent of the mass shift indicates what residue(s) is/are present by 
comparing data from both before and after oxidation; thus, performic acid oxidation 
gives crucial information when comparing several protein matches returned from a PMF 
experiment due to the low frequency of abundance of cysteine, methionine, and 
tryptophan residues.  Use of negative polarity in MALDI also increases the confidence  
of protein identification by yielding cysteic acid-containing peptides that previously 
might have not been observed in the unoxidized sample which increases the total 
sequence coverage.   
RESULTS AND DISCUSSION 
Five Protein Mixture-Myo, Ova, Phos, Ribo, TF 
   Positive mode MALDI data was utilized in the unoxidized protein digest 
mixture alone due to the lack of additional information gathered in negative mode for 
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protein digests in the previous studies (Chapter III and IV).  Monoisotopic masses for the 
observed peaks were submitted to ProFound for PMF identification.  Iterative searches 
can be performed by eliminating masses that correspond to a protein and resubmitting 
the remaining masses.48  Even with a mass error of 25 ppm, searches done in ProFound 
could not be performed by specifying all taxa due to the number of false positives.  Due 
to Ova being from a different taxonomic category than the other four proteins, “other 
chordata” and “other mammalia” had to be interchanged to identify Ova and the other 
four proteins respectively.  
 Using the data obtained in positive mode MALDI of the unoxidized digest 
mixture, Phos, TF, Ova, and Myo were identified by PMF identification; Ribo was not 
returned as a possible match.  After manual inspection of the observed masses, no peaks 
corresponding to Ribo tryptic peptides were detected.   The oxidized mixture data 
obtained from positive mode MALDI was queried for PMF identification.  Phos, TF, 
Ova, and Myo were, again, identified.  Ribo was not retrieved in positive mode MALDI 
data after oxidation.  With TF as the exception, Phos, Ova, and Myo all gained in 
percent coverage by 8%, 5%, and 7% respectively.  Overall, ~50% more peptides with 
methionine sulfone were detected, and almost all peptides with tryptophan were not 
detected in positive mode MALDI of the oxidized sample.  This observation indicates 
that methionine sulfone may aid in the positive mode ionization efficiency of some 
peptides.     
 Negative ion data from the oxidized digest, after database searching, yielded 
different results.   All five protein components were identified.  Ribo had a percent 
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coverage of 40% due to the detection of three peptides, all of which, contain cysteic 
acid.  Of all the 56 peaks identified as a peptide by PMF experiments, over 50% of the 
peptides contained at least one cysteic acid.  Peptides identified as containing methionine 
sulfone or singly-oxidized tryptophan typically contained a cysteic acid residue as well; 
the presence of a cysteic acid residue possibly aided in the detection of these peptides. 
Ten Protein Mixture-AC-S1, AC-S2, Ald, BC, BSA, Myo, Ova, Phos, Ribo, TF 
 PMF identification with a larger number of proteins became more complicated 
when using either Mascot or ProFound.  High molecular weight proteins, e.g., TF, Phos, 
and BSA, were favored over the lower weight proteins, e.g., Myo, AC-S1, AC-S2.  The 
large amount of queried masses possibly caused the favoring of high kDa proteins due to 
the scoring algorithm used in the search engine.  To correct for scoring bias, protein 
mass ranges were specified (in kDa) and increased as iterative searches progressed.   
 With positive mode MALDI of the unoxidized mixture, eight of the ten proteins 
were identified using the molecular weight range modification.  Ribo and BC were not 
identified, and peaks corresponding to the tryptic peptides were not observed when 
manually inspecting the spectrum.  Positive mode data from the oxidized sample did not 
yield a match to Ribo and BC as well.  As seen from interpretation of the five protein 
mixture data, oxidation increased the number of peptides containing methionine roughly 
50%, although the number of tryptophan-containing peptides observed remained the 
same when compared to positive mode MALDI data of the unoxidized sample.   
 Negative mode MALDI data of the oxidized mixture matched 8 of the 10 
proteins by PMF identification.  Ribo was identified by detection of two cysteic acid-
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containing peptides.  Masses corresponding to peptides of AC-S2 and BC were not 
observed.  As observed in the five protein digest mixture, over half of the matched 
peptides contained cysteic acid, and the majority of peptides observed that contain 
methionine sulfone also contain cysteic acid.      
Fifteen Protein Mixture- AC-S1, AC-S2, Ald, BC, BSA,CA, CytC, Hemo-α, Hemo-β, Lys, 
Myo, Ova, Phos, Ribo, TF  
 The complexity of the fifteen protein mixture also warranted limiting the protein 
mass range while performing iterative PMF identification queries.  Positive mode 
MALDI data of the unoxidized mixture matched 13 of the 15 proteins present; no peaks 
were observed that corresponded to Ribo and AC-S2.  Of the 83 peaks identified, only 
18 contained oxidizable residues half of which contained tryptophan.  For the oxidized 
15 protein component mixture, positive mode MALDI  data matched 13 of the 15 
proteins.  After submission of the oxidized mixture data to the search engine, 17 peptides 
contained oxidized residues, 9 of which contained methionine sulfone.  Again, as in 
positive mode MALDI data of the unoxidized sample, AC-S2 and Ribo were not 
identified.  
 PMF identification of the oxidized mixture using negative mode MALDI data 
resulted in identification of only 10 of the 15 proteins.  The proteins not identified were 
AC-S1, AC-S2, BC, CA, and CytC.  When referring to Table 1, these five proteins are 
among those with the lesser amount of cysteine residues; thus, the lack of cysteic acid 
may be responsible for the lower number of protein identifications.  Even though Myo 
and Hemo-α contain no cysteine, one or more of their tryptic peptides, whether or not an 
 42
oxidizable residue is present, typically had a strong signal intensity that allowed for 
identification.    Over half of the peaks identified as peptides did contain cysteic acid, 
and of the peptides containing methionine sulfone, the majority also contained cysteic 
acid.  Only two peptides contained singly-oxidized tryptophan alone.   
Combined Unoxidized and Oxidized Sequence Coverage for Protein Digest Mixtures 
 Although sufficient numbers of protein are identified by a single mode of 
analysis, enhanced results can be achieved by combining several approaches.  In 
addition, percent coverage for proteins identified in the unoxidized, positive mode data 
by PMF increased using the combined unoxidized/oxidized data set.   For example, the 
percent coverage for Ald (fifteen protein mixture) obtained using positive mode 
unoxidized data was 12%; whereas, the percent coverage for Ald (fifteen protein 
mixture) was determined to be 43% using a combined unoxidized/oxidized data set.  On 
average, percent coverage for the positive mode, unoxidized fifteen component protein 
mixture was 23%, and increased to 33% using the combined data set.  Generally, percent 
coverage for each protein component decreased as the sample complexity increased, 
although a combined approach of unoxidized/oxidized data always provided the same or 
better percent coverage for individual proteins in a complex mixture.   
 Furthermore, by comparison of unoxidized and oxidized MALDI spectra of 
complex mixtures of proteins after trypsin digestion, the possible protein components in 
a biological mixture identified in PMF experiments can be further refined to eliminate 
any false positives.  After performic acid oxidation, the elimination of erroneous protein 
matches can simply be done by the observation of a specific mass shift, or lack thereof, 
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in the peptide ion purported to have a sequence with cysteine, methionine, and/or 
tryptophan residues.   
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CHAPTER VI 
“ON-TARGET” PERFORMIC ACID OXIDATION OF 
 
 THERMALLY-DENATURED TRYPTIC DIGESTS 
 
 
BACKGROUND 
 
 In-solution performic acid oxidation, according to the protocol utilized in this 
study (Chapter III, IV, V), consumes close to five hours of sample preparation time.  In 
order to make this oxidation adaptable to a high-throughput approach, a quicker 
procedure that retains the oxidative power of the in-solution protocol must be created.  In 
addition, the ability to conserve the amount of the available sample would greatly aid in 
situations where sample is limited.  A dried-droplet MALDI sample can be analyzed in 
both polarities; the sample plate ejected from the instrument, and an oxidation solution 
applied directly onto the previously irradiated sample spot and allowed to dry.  The same 
sample spot can now be analyzed as an oxidized digest.  Unfortunately, the majority of 
matrices used in MALDI are soluble in organics and performic acid is an aqueous 
solution.  In addition, other pitfalls include unwanted side products (i.e., chlorinated 
tyrosine), can occur when performic acid oxidation is performed at ambient 
temperatures.29,31  Bondanarko et al.,32 accomplished an “on-target” oxidation with 
performic acid directly on a MALDI sample tip, although the details of the procedure 
utilized are not disclosed in the manuscript.   
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RESULTS AND DISCUSSION 
 Positive and negative ion spectra of the thermally-denatured tryptic digests of 
unoxidized BSA and TF were similar in appearance to previous samples, and after 
submission of the observed peaks to Mascot, the percent coverage fell within the 
standard deviation of the average of the respective proteins in Chapter IV.  After ejecting 
the sample stage from the instrument, various ratios of oxidizing solution were deposited 
onto the sample spot and allowed to evaporate.  The extent to which the α-cyano-4-
hydroxycinnamic acid crystals dissolved was visual inspected.  In every case where 
performic acid was mixed with the organic solution and directly deposited on top of the 
dried-droplet, the matrix crystals did not appear to dissolve completely.  After 
evaporation, the peaks corresponding to peptides with oxidizable residues had not 
shifted in mass, indicating that no oxidation occurred.  When the methanol alone was 
applied, the lack of surface tension caused the methanol droplet to spread rapidly into 
other sample spots on the MALDI plate causing cross-contamination.  An equal volume 
of acetonitrile was mixed with the methanol to increase the surface tension and prevent 
“spreading”.  After applying the acetonitrile/methanol mixture, the matrix crystals 
dissolved, and 1 µL of performic acid was added to the sample droplet.  The matrix 
crystals were significantly smaller after the oxidant mixture had evaporated.  The sample 
was analyzed by MALDI in the same manner as described previously.    
 Compared to in-solution performic acid oxidation, applying the oxidant solution 
directly on top of a MALDI sample spot resulted in degradation of spectral quality.  
Average signal-to-noise ratio (S/N) decreased by a factor of 5 upon oxidation (Figure 
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10).  Only peptide ion signals that typically have high signal intensity when oxidized in-
solution were detected.  It is possible that residual oxidant may have become 
encapsulated inside the matrix crystals, leading to an increase in chemical noise.  The 
solvent composition of matrix/analyte solution can influence MALDI spectral quality. 
For example, recent results suggest that the solvent-dependant conformation of peptides 
can influence MALDI ionization efficiency.23     
 Despite the relatively poor signal quality, the method utilized successfully 
oxidized the peptide sample.  Masses corresponding to unoxidized peptides with 
cysteine, methionine, and/or tryptophan were not detected.  No methionine sulfoxide-
containing peptides were observed indicating that oxidation was complete.  In the case 
of tryptophan-containing peptides, the dominant oxidized form was that of N-
formylkynurenine, the doubly-oxidized species (Figure 11).  This differs from in-
solution performic acid oxidation where  β-(3-oxyindolyl)alanine-containing (+O) 
peptide peaks are dominant.  The performic acid concentration used for on-target 
oxidation and the presence of matrix can be ruled out as causes for the observation.  In 
preliminary studies with single peptides, the 1:32 ratio of performic acid was used with 
no matrix present, and the +O2 oxidized tryptophan species was also the most dominant. 
The probable cause for the shift in the dominant oxidized species is due to the higher 
temperature allowed in on-target oxidation.    
 Using the complete, doubly-oxidized tryptophan modification in ProFound, 
positive and negative ion data from the on-target oxidation of BSA and TF were queried.  
The PMF identification of positive ion data for both BSA and TF had percent coverages  
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Figure 10.  Representative negative mode MALDI spectra of TF when oxidized (A) in-solution 
and (B) “on-target”.   
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Figure 11.   Positive mode MALDI spectra of the tryptic peptide 
EDVIWELLNHAQEHFGK after “on-target” performic acid oxidation. 
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that fell lower than the average range for oxidized, positive ion percent coverage of the 
proteins oxidized in-solution in Chapter IV.   Percent coverage obtained from oxidized,  
negative ion data fell to approximately half of the percentages obtained from in-solution 
oxidization.  When oxidized positive and negative ion MALDI data were combined, 
BSA and TF percent coverage was also below the average range for the same combined 
data obtained under in-solution oxidation (Chapter IV).   
 The total-combined percent coverage obtained from combining the four sets of 
data (unoxidized positive/negative and oxidized positive/negative) for BSA was ~20% 
lower than the total-combined percent coverage of BSA in Chapter IV.  The percent 
coverage observed from the combination of TF data was within the average range for 
total-combined percent coverage of TF reported in Chapter IV.     
 50
CHAPTER VII 
 
CONCLUSIONS 
 
 
 Performic acid oxidation of tryptic protein digests alters the chemical nature of 
peptides that contain cysteine, methionine, and/or tryptophan residues.  Dependant on 
the amino acid composition of a protein, oxidation can aid in increasing sequence 
coverage when the digest is analyzed by MALDI in positive and negative polarity and 
the data is submitted for PMF identification.  Oxidation influences sequence coverage by 
enhancing ionization efficiency of some peptides and reducing mass spectral overlap for 
oxidizable peptide ion signals that are eclipsed by an unoxidizable peptide.  High 
confidence identification of a protein by PMF can be obtained by observing mass shifts 
in peaks corresponding to a peptide with an oxidizable residue when comparing spectra 
from before and after oxidation due to the low frequency of abundance of cysteine, 
methionine, and tryptophan residues in proteins.  A shift of +32 Da indicates the 
presence of methionine, whereas a mass shift of +48 Da confirms the presence of 
cysteine.  Despite the detection of fewer tryptophan-containing peaks in MALDI after 
performic acid oxidation, observing the emergence of a triplet of peaks with 16 Da gaps, 
confirms the presence of tryptophan.  Thus, the mass shifts of cysteine, methionine, 
and/or tryptophan can greatly enhance confidence when performing PMF protein 
identifications. 
 After detailed analyses of MALDI spectra of oxidized protein digests and protein 
digest mixtures, peptides with methionine sulfone are best detected in positive mode, 
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and those with cysteic acid are best detected in negative mode.  Methionine oxidation 
may add to the basicity of the peptide to enhance the probability of protonation.  It is 
also important to note that high m/z peaks, corresponding to either an oxidized peptide 
or not, were more readily detected in positive mode MALDI of oxidized digests.  Due to 
the high acidity of cysteic acid, cysteic acid-containing peptides more readily loose a 
proton, and thus are more easily detected in negative mode MALDI.  The majority of 
cysteine-containing peptides are not observed prior to oxidation in the proteins used here 
(Table 1).  
 Performic acid oxidation can be performed “on-target” by directly applying an 
organic solution onto a dried-droplet MALDI sample immediately followed by the 
oxidant solution.  This approach to oxidation allows rapid data acquisition of the same 
sample before and after oxidation, and allows micro scale oxidation when sample 
volume is limited.  To correct for the degradation of spectral quality after “on-target” 
oxidation, acetone redeposition46,49 or applying additional matrix solution may be used 
as a third application after complete evaporation of the oxidant solution.  These 
additional applications may free any residual oxidant that may become incorporated into 
matrix crystals.   
 After an optimized protocol is determined, performic acid oxidation can be 
adapted to high-throughput, automated proteomics experiments.  For example, samples 
analyzed by electrospray ionization mass spectrometry (ESI-MS) could be mixed using a 
flow-injection (FI) method where a long reaction capillary is used to perform on-line 
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oxidation prior to ESI.  Also, MALDI sample oxidation can be automated using 
commercially-available robotic sample handling devices. 
 Future experiments will involve time trials of in-solution oxidation to determine 
if the 180 min incubation period of tryptic digests is truly necessary for complete 
oxidation.  When performic acid oxidation is performed “on-target”, complete oxidation 
can be performed in ~10 min although the temperature environment is ~ 30°C higher 
than when oxidation is performed in-solution.  Temperature should also be varied when 
conducting in-solution oxidation since the +O2 tryptophan species becomes the most 
dominant when oxidation is performed “on-target”.  At temperatures above 25°C, the 
triply-oxidized tryptophan may become more dominant.  The best case scenario for 
tryptophan oxidation would be restricting oxidation to only the singly-oxidized species 
when dealing with a true unknown; then, the amount of additional oxygen atoms would 
correlate only to tryptophan, methionine, or cysteine.   
 Performic acid oxidation is extremely useful in an additional manner concerning 
PMF identification of proteins.  In instances where PMF experiments return a number of 
highly-scored protein matches that are theoretically possible as components in the 
biological sample, performic acid oxidation can be used to identify the true protein(s) 
present.  Comparing the proposed peptide sequence reported by the search engine as 
matching with the mass shift, if any, of the m/z after performic acid oxidation will either 
enhance or refute the validity of the PMF protein identification due to the ability of 
cysteine, methionine, and tryptophan to incorporate a specific number of oxygen atoms.  
Observing any mass shifts of masses corresponding to purported peptides, coupled with 
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the low frequency of occurrence of cysteine, methionine, and tryptophan residues in 
proteins, adds an even higher amount of confidence in PMF identifications of proteins.   
Therefore, performic acid oxidation is of great utility when used in conjunction with 
peptide mass fingerprinting protein identification. 
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